These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 30476973)

  • 1. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
    Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
    JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau.
    Roth A; Jensen H; Garly ML; Djana Q; Martins CL; Sodemann M; Rodrigues A; Aaby P
    Pediatr Infect Dis J; 2004 Jun; 23(6):544-50. PubMed ID: 15194836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG vaccination reaction in low birth weight infants.
    Kaur S; Faridi MM; Agarwal KN
    Indian J Med Res; 2002 Aug; 116():64-9. PubMed ID: 12592992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.
    Saroha M; Faridi MM; Batra P; Kaur I; Dewan DK
    Hum Vaccin Immunother; 2015; 11(12):2864-71. PubMed ID: 26431252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
    Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
    Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculin conversion and leukocyte migration inhibition test after BCG vaccination in newborn infants.
    Faridi M; Kaur S; Krishnamurthy S; Kumari P
    Hum Vaccin; 2009 Oct; 5(10):690-5. PubMed ID: 19855160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculin reaction and BCG scar: association with infant mortality.
    Timmermann CA; Biering-Sørensen S; Aaby P; Fisker AB; Monteiro I; Rodrigues A; Benn CS; Ravn H
    Trop Med Int Health; 2015 Dec; 20(12):1733-44. PubMed ID: 26426863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
    Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
    Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guerin vaccination in preterm infants.
    Okan F; Karagoz S; Nuhoglu A
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1337-41. PubMed ID: 17167949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2004; (1):CD000361. PubMed ID: 14973955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2001; (2):CD000361. PubMed ID: 11405962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculin response in preterm infants after BCG vaccination at birth.
    Sedaghatian MR; Kardouni K
    Arch Dis Child; 1993 Sep; 69(3 Spec No):309-11. PubMed ID: 8215572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
    Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
    Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2013 Jul; (7):CD000361. PubMed ID: 23821390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacille Calmette Guérin vaccination in pre-term infants.
    Sedaghatian MR; Hashem F; Moshaddeque Hossain M
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):679-82. PubMed ID: 9712284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women.
    Thaithumyanon P; Thisyakorn U; Punnahitananda S; Praisuwanna P; Ruxrungtham K
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):482-6. PubMed ID: 11289006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculin conversion following BCG vaccination in preterm infants.
    Dawodu AH
    Acta Paediatr Scand; 1985 Jul; 74(4):564-7. PubMed ID: 4024927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2000; (2):CD000361. PubMed ID: 10796199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.
    Pang Y; Kang W; Zhao A; Liu G; Du W; Xu M; Wang G; Zhao Y; Zheng S
    Vaccine; 2015 Jan; 33(1):209-13. PubMed ID: 25454854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.